HONG KONG – The China Securities Regulatory Commission (CSRC) said Friday it plans to lift the four-month ban on IPOs that started during a bout of extreme volatility in the financial markets in Mainland China throughout June and July.
HONG KONG — One of the biggest Chinese medical device companies is undergoing a $3 billion delisting from the U.S. market as it paves the way to head back to its home market and the possibility of more access to investment.
HONG KONG – The China Securities Regulatory Commission (CSRC) said Friday it plans to lift the four-month ban on IPOs that started during a bout of extreme volatility in the financial markets in Mainland China throughout June and July.
HONG KONG – Genes are no longer patentable in Australia after the country's highest court overturned last week two earlier decisions by a federal court and ruled that a gene linked to an increased risk of breast and ovarian cancer cannot be patented.
HONG KONG – Genes are no longer patentable in Australia after the country's highest court overturned on Wednesday two earlier decisions by a federal court and ruled that a gene linked to an increased risk of breast and ovarian cancer cannot be patented.
